Antioxidant Intervention Attenuates Myocardial Neovascularization in Hypercholesterolemia

Circulation

Volumn 109, Issue 17, 2004, Pages 2109-2115

  Zhu, Xiang Yang ^a,e   Rodriguez Porcel, Martin ^a   Bentley, Michael D ^c   Chade, Alejandro R ^a   Sica, Vincenzo ^d   Napoli, Claudio ^d   Caplice, Noel ^a   Ritman, Erik L ^b   Lerman, Amir ^a   Lerman, Lilach O ^a,f  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

^c MINNESOTA STATE UNIVERSITY   (United States)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^e XINHUA HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^f Mayo Clinic   (United States)

Author keywords

Antioxidant; Atherosclerosis; Hypercholesterolemia; Oxidative stress

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; CHOLESTEROL; GROWTH FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; COMPUTED TOMOGRAPHY SCANNER; CONTROLLED STUDY; DIET SUPPLEMENTATION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HYPERCHOLESTEROLEMIA; LIPID DIET; MICROVASCULATURE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SWINE;

ANIMALS; ANTIOXIDANTS; ARTERIOSCLEROSIS; ASCORBIC ACID; CARDIOTONIC AGENTS; CORONARY CIRCULATION; DIET, ATHEROGENIC; DINOPROST; ENZYME INDUCTION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HEART; HYPERCHOLESTEROLEMIA; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMAGING, THREE-DIMENSIONAL; MYOCARDIAL ISCHEMIA; NEOVASCULARIZATION, PATHOLOGIC; OXIDATIVE STRESS; SUPEROXIDE DISMUTASE; SWINE; TOMOGRAPHY, X-RAY COMPUTED; TRANSCRIPTION FACTORS; TYROSINE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VITAMIN E;

EID: 2442499548     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000125742.65841.8B     Document Type: Article

References (42)

1. Napoli C, Lerman LO. Involvement of oxidation-sensitive mechanisms in the cardiovascular effects of hypercholesterolemia. Mayo Clin Proc. 2001;76:619-631.
2. Wilson SH, Simari RD, Best PJ, et al. Simvastatin preserves coronary endothelial function in hypercholesterolemia in the absence of lipid lowering. Arterioscler Thromb Vasc Biol. 2001;21:122-128.
3. Rodriguez-Porcel M, Lerman A, Best PJ, et al. Hypercholesterolemia impairs myocardial perfusion and permeability: role of oxidative stress and endogenous scavenging activity. J Am Coll Cardiol. 2001;37:608-615.
4. Rodriguez-Porcel M, Lerman LO, Holmes DR Jr, et al. Chronic antioxidant supplementation attenuates nuclear factor-kappa B activation and preserves endothelial function in hypercholesterolemic pigs. Cardiovasc Res. 2002;53:1010-1018.
5. Rodriguez-Porcel M, Lerman A, Ritman EL, et al. Altered myocardial microvascular 3D architecture in experimental hypercholesterolemia. Circulation. 2000;102:2028-2030.
6. Gao N, Ding M, Zheng JZ, et al. Vanadate-induced expression of hypoxia-inducible factor I alpha and vascular endothelial growth factor through phosphatidylinositol 3-kinase/Akt pathway and reactive oxygen species. J Biol Chem. 2002;277:31963-31971.
7. Chandel NS, Maltepe E, Goldwasser E, et al. Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc Natl Acad Sci USA. 1998;95:11715-11720.
8. Shibuya M. Structure and function of VEGF/VEGF-receptor system involved in angiogenesis. Cell Struct Funct. 2001;26:25-35.
9. Li J, Brown LF, Hibberd MG, et al. VEGF, flk-1, and fit-1 expression in a rat myocardial infarction model of angiogenesis. Am J Physiol. 1996;270:H1803-H1811.
10. Kuroki M, Voest EE, Amano S, et al. Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo. J Clin Invest. 1996;98:1667-1675.
11. Borkowski A, Younge BR, Szweda L, et al. Reactive nitrogen intermediates in giant cell arteritis: selective nitration of neocapillaries. Am J Pathol. 2002;161:115-123.
12. Jorgensen SM, Demirkaya O, Ritman EL. Three-dimensional imaging of vasculature and parenchyma in intact rodent organs with x-ray micro-CT. Am J Physiol. 1998;275:H1103-H1114.
13. Smedby O, Bergstrand L. Tortuosity and atherosclerosis in the femoral artery: what is cause and what is effect? Ann Biomed Eng. 1996;24:474-480.
14. Krier JD, Rodriguez-Porcel M, Best PJ, et al. Vascular responses in vivo to 8-epi PGF(2alpha) in normal and hypercholesterolemic pigs. Am J Physiol. 2002;283:R303-R308.
15. Herrmann J, Lerman LO, Rodriguez-Porcel M, et al. Coronary vasa vasorum neovascularization precedes epicardial endothelial dysfunction in experimental hypercholesterolemia. Cardiovasc Res. 2001;51:762-766.
16. Bentley MD, Rodriguez-Porcel M, Lerman A, et al. Enhanced renal cortical vascularization in experimental hypercholesterolemia. Kidney Int. 2002;61:1056-1063.
17. Poon RT, Lau CP, Cheung ST, et al. Quantitative correlation of serum levels and tumor expression of vascular endothelial growth factor in patients with hepatocellular carcinoma. Cancer Res. 2003;63:3121-3126.
18. Hinson JA, Michael SL, Ault SG, et al. Western blot analysis for nitrotyrosine protein adducts in livers of saline-treated and acetaminophentreated mice. Toxicol Sci. 2000;53:467-473.
19. Miyagi M, Sakaguchi H, Darrow RM, et al. Evidence that light modulates protein nitration in rat retina. Mol Cell Proteomics. 2002;1:293-303.
20. Baumgartner I, Pieczek A, Manor O, et al. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation. 1998;97:1114-1123.
21. Hutchins GM, Miner MM, Bulkley BH. Tortuosity as an index of the age and diameter increase of coronary collateral vessels in patients after acute myocardial infarction. Am J Cardiol. 1978;41:210-215.
22. Dollery CM, Owen CA, Sukhova GK, et al. Neutrophil elastase in human atherosclerotic plaques: production by macrophages. Circulation. 2003;107:2829-2836.
23. Hayashi A, Ryu A, Suzuki T, et al. In vitro degradation of tropoelastin by reactive oxygen species. Arch Dermatol Res. 1998;290:497-500.
24. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999;340:115-126.
25. Bendeck MP. Mining the myocardium with macrophage drills: a novel mechanism for revascularization. Circ Res. 2000;87:341-343.
26. 2 sensing. J Biol Chem. 2000;275:25130-25138.
27. MacMillan-Crow LA, Crow JP, Thompson JA. Peroxynitrite-mediated inactivation of manganese superoxide dismutase involves nitration and oxidation of critical tyrosine residues. Biochemistry. 1998;37:1613-1622.
28. MacMillan-Crow LA, Crow JP, Kerby JD, et al. Nitration and inactivation of manganese superoxide dismutase in chronic rejection of human renal allografts. Proc Natl Acad Sci U S A. 1996;93:11853-11858.
29. Kinscherf R, Kohler C, Kreuter C, et al. Hypercholesterolemia increases manganese superoxide dismutase immunoreactive macrophages in myocardium. Histochem Cell Biol. 1995;104:295-300.
30. Kakkar R, Mantha SV, Kalra J, et al. Time course study of oxidative stress in aorta and heart of diabetic rat. Clin Sci (Lond). 1996;91:441-448.
31. t Hoen PA, Van der Lans CA, Van Eck M, et al. Aorta of apoE-deficient mice responds to atherogenic stimuli by a prelesional increase and subsequent decrease in the expression of antioxidant enzymes. Circ Res. 2003;93:262-269.
32. Duyndam MC, Hulscher TM, Fontijn D, et al. Induction of vascular endotheiial growth factor expression and hypoxia-inducible factor 1alpha protein by the oxidative stressor arsenite. J Biol Chem. 2001;276:48066-48076.
33. Marumo T, Schini-Kerth VB, Busse R. Vascular endothelial growth factor activates nuclear factor-kappaB and induces monocyte chemoattractant protein-1 in bovine retinal endothelial cells. Diabetes. 1999;48:1131-1137.
34. Colavitti R, Pani G, Bedogni B, et al. Reactive oxygen species as downstream mediators of angiogenic signaling by vascular endothelial growth factor receptor-2/KDR. J Biol Chem. 2002;277:3101-3108.
35. Salomonsson L, Pettersson S, Englund MC, et al. Post-transcriptional regulation of VEGF expression by oxidised LDL in human macrophages. Eur J Clin Invest. 2002;32:767-774.
36. Maulik N, Das DK. Redox signaling in vascular angiogenesis. Free Radic Biol Med. 2002;33:1047-1060.
37. Weis M, Heeschen C, Glassford AJ, et al. Statins have biphasic effects on angiogenesis. Circulation. 2002;105:739-745.
38. Salonen RM, Nyyssonen K, Kaikkonen J, et al. Six-year effect of combined vitamin C and E supplementation on atherosclerotic progression: the Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) Study. Circulation. 2003;107:947-953.
39. Yusuf S, Dagenais G, Pogue J, et al. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000;342:154-160.
40. Stephens NG, Parsons A, Schofield PM, et al. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet. 1996;347:781-786.
41. Mohlenkamp S, Behrenbeck TR, Lerman A, et al. Coronary microvascular functional reserve: quantification of long-term changes with electron-beam CT preliminary results in a porcine model. Radiology. 2001;221:229-236.
42. Rodriguez-Porcel M, Lerman A, Herrmann J, et al. Hypertension exacerbates the effect of hypercholesterolemia on the myocardial microvasculature. Cardiovasc Res. 2003;58:213-221.